Two kinds of botulinum toxin type A were clinically evaluated in rhytidectomy. Twenty Korean patients with facial wrinkles were fully assessed following treatments with random injections. The mean degree of wrinkles before the injections was 2.83 and the mean corrective effect was 70.0% at least 3 months afterward. The effect lasted less than 6 months in only 9 cases. The complications were tingling sensations in 3 cases (15.0%), temporary lid swelling in 5 cases (25.0%) and lagophthalmos in 3 cases (15.0%). No serious or permanent adverse effects were observed. Botulinum toxin type A rhytidectomy was a very effective method of removing various facial wrinkles although the treatment for complications and side effects will need to be considered.

Keywords:
Botulinum toxin A, Facial wrinkles
1.
Carruthers A, Carruthers J: Botulinum toxin in the treatment of glabellar frown lines and other facial wrinkles; in Jankovic J, Hallett M (eds): Therapy with Botulinum Toxin. New York, Dekker, 1994.
2.
Guyuron B, Huddleston SW: Aesthetic indications for botulinum toxin injection. Plast Reconstr Surg 1994;93:913–918.
3.
McCurdy JA: Cosmetic Surgery of the Asian Face. New York, Thieme Medical Publishers, 1990.
4.
Nussgens Z, Roggenkamper P: Comparison of two botulinum-toxin preparations in the treatment of essential blepharospasm. Graefes Arch Clin Exp Ophthalmol 1997;235:197–199.
5.
Kligman LH: Photoaging. Manifestations, prevention, and treatment. Dermatol Clin 1986;4:517–528.
6.
Blitzer A, Brin M, Keen MS, Aviv JE: Botulinum toxin for the treatment of hyperfunctional lines of the face. Arch Otolaryngol Head Neck Surg 1993;119:1018–1022.
7.
Buckley EG: Chemodenervation of extraocular muscles; in Tasman W (ed): Duane’s Clinical Ophthalmology, ed 3. Philadelphia, Lippincott, 1993, pp 1–14.
8.
Keen M, Kopelman JE, Aviv JE, Binder W, Brin M, Blitzer A: Botulinum toxin A: A novel method to remove periorbital wrinkles. Facial Plast Surg 1994;10:141–146.
9.
Scott AB: Botulinum toxin injection of eye muscles to correct strabismus. Trans Am Ophthalmol Soc 1981;79:734–770.
© 2002 S. Karger AG, Basel
2002
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.